On September 21, 2023 NKGen Biotech, Inc. ("NKGen" or the "Company"), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic, and CAR-NK natural killer ("NK") cell therapies, reported that its Executive Leadership will present at the Cantor Fitzgerald 2023 Global Healthcare Conference on Wednesday, September 27, 2023, in New York City (Press release, NKMax America, SEP 21, 2023, View Source [SID1234635312]). Please see details below:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Cantor Fitzgerald Global Healthcare Conference
Format: Company presentation
Date: Wednesday, September 27, 2023
Time: 4:45 pm ET
Location: New York, NY
The webcast will be accessible on the Events & Presentations page in the Investors section of the Company’s website at www.nkgenbiotech.com beginning on the day of the event.